Intravenous (IV) Hydration Therapy Market Thumbnail Image

2024

Intravenous (IV) Hydration Therapy Market

Intravenous (IV) Hydration Therapy Market Size, Share, Competitive Landscape and Trend Analysis Report, by Service, by Component, by End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

LS : Therapeutics

Select an option
Author's: NA | Roshan Deshmukh
Publish Date:

Get Sample to Email

Intravenous (IV) Hydration Therapy Market Research, 2033

The global IV hydration therapy market size was valued at $2.3 billion in 2023, and is projected to reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.Increase in prevalence of dehydration-related conditions and rise in aging population are driving theIV Hydration Therapy Market Forecasty Market . 

 

Intravenous (IV) Hydration Therapy Market

Market Introduction and Definition 

Intravenous (IV) hydration therapy is a medical treatment that involves the direct infusion of fluids, electrolytes, vitamins, and sometimes medications into the bloodstream through a vein. This method ensures rapid and efficient replenishment of essential fluids and nutrients, making it highly effective for treating dehydration caused by illness, intense physical activity, or excessive alcohol consumption. IV hydration therapy is also used in medical settings for preoperative and postoperative care, chronic conditions management, and as a supportive treatment for patients with severe infections or gastrointestinal issues. Its ability to quickly restore hydration and electrolyte balance makes it a valuable therapeutic option in both clinical and wellness contexts. 

Key Takeaways 

  • The IV hydration therapy market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period. 
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major IV hydration therapy industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights. 
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.

Key Market Dynamics 

One of the primary drivers of this IV hydration therapy market growth  is the increasing prevalence of dehydration-related conditions. As lifestyles become more hectic, with higher levels of physical activity and stress, the incidence of dehydration and associated ailments is rising. This trend is particularly notable among athletes, busy professionals, and individuals in hot climates. IV hydration therapy offers a quick and effective solution for rehydration, delivering fluids and electrolytes directly into the bloodstream for rapid relief. This immediacy and efficiency make it a preferred choice for many, fueling market growth. Additionally, the growing awareness of health and wellness contributes to the demand, as people seek optimal hydration for enhanced physical and mental performance. 

Despite the promising growth drivers, the market faces significant restraints, one of the most critical being the high cost of IV hydration therapy. The expense includes not only the cost of fluids and nutrients but also the fees for professional administration by licensed healthcare providers. These high costs can limit access for many potential users, particularly in low- and middle-income regions. Furthermore, the need for professional administration also introduces logistical challenges and increases the overall expense, which can deter widespread adoption. 

Moreover, technological advancements present a significant opportunity for IV hydration therapy market forecasty market growth. Innovations in portable and user-friendly IV therapy equipment can make the therapy more accessible and convenient, reducing the need for hospital visits. Development of home IV hydration kits and mobile IV services can expand the market reach, catering to busy individuals who prefer in-home treatments. Additionally, advancements in telemedicine could allow for remote monitoring and guidance, making IV hydration therapy more efficient and patient-centric. These technological improvements can lower costs, improve accessibility, and enhance patient outcomes, presenting a substantial growth opportunity for the IV hydration therapy market. 

Market Segmentation 

The IV hydration therapy industry is segmented into  service, component, end user and region. Based on  service, the market is segmented  into immune boosters, energy boosters, skin care, migraine, and others. By component, it is segmented into medicated and non-medicated. As per end user, it is  categorized into hospital & clinics, wellness centers & spas, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Regional/Country Market Outlook 

The IV hydration therapy market share exhibits regional variations in growth and demand. North America leads the market, driven by high health and wellness awareness, advanced healthcare infrastructure, and significant disposable income. Europe follows, with growing adoption in wellness tourism and increasing prevalence of dehydration-related conditions. The Asia-Pacific region is experiencing rapid IV hydration therapy market trends due to rising health awareness, expanding healthcare access, and a burgeoning middle class. Emerging markets in Latin America and the Middle East are also expanding, fueled by improving healthcare infrastructure and increasing medical tourism, despite challenges such as regulatory constraints and higher costs limiting widespread adoption. 

  • Drip Hydration company in the U.S. provides Stomach Flu IV treatment, which includes a blend of electrolytes, vitamins, fluids, and medications to alleviate stomach flu symptoms and rehydrate the body within 30-60 minutes. This IV therapy contains Vitamin B12, B-Complex vitamins, Vitamin C, Zofran, and Pepcid. Zofran, an anti-nausea medication, helps reduce nausea and vomiting associated with stomach flu. 

Industry Trends 

  • In August 2022, according to the health spending statistics published by OECD, it was reported that in the United States, voluntary healthcare spending per capita accounted for USD 1, 807, and out-of-pocket spending on healthcare also increased which accounted for USD 1, 225 per capita in the past year. 

Common Causes of Dehydration for Global Intravenous (IV) Hydration Therapy Market 

The global IV hydration therapy market is influenced by various factors causing dehydration. According to the data, diarrhea is the leading cause at 73%, significantly driving the demand for IV hydration to quickly restore lost fluids and electrolytes. Sweating and vomiting, each at 52%, are also major contributors, common in athletic activities and illnesses, respectively. Fever (40%) increases fluid loss through elevated body temperature, while increased urination (36%) can result from medical conditions or medications. Travel, at 16%, often leads to dehydration due to changes in routine and environmental conditions. These factors collectively highlight the diverse needs addressed by IV hydration therapy globally.

Common causes of dehydration for Global Intravenous (IV) hydration therapy Market

Factors

% Cause

Diarrhoea

73

Sweating

52

Vomiting 

52

Fever

40

Increased urination 

36

Travel

16

Competitive Landscape 

The major players operating in the IV hydration therapy market size include Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co.Ltd., ?NexGen Health, JW Life Science Corporation, Amanta Healthcare, Baxter International Inc., and Drip Hydration. 

Other players in intravenous (IV) hydration therapy market include Terumo Corporation, AngioDynamics, Inc., Fresenius SE and Co. KGaA, Pfizer Inc, Telefle, Medtronic Inc, Cardinal Health Inc., Smiths Medical and so on. 

Recent Key Strategies and Developments 

  • In February 2022, Access Vascular, Inc. (AVI) , announced its partnership with Healthcare Insights (HCIS) to build a value-based care program that can more broadly support hospital customers as they deploy the company’s groundbreaking biomaterial-based catheters to improve vascular access medical and economic outcomes. 

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the IV hydration therapy market analysis from 2024 to 2033 to identify the prevailing IV hydration therapy market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intravenous (IV) hydration therapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intravenous (IV) hydration therapy market trends, key players, market segments, application areas, and market growth strategies.

Key Sources Referred 

  • World Health Organization (WHO)  
  • National Center for Biotechnology and Information (NCBI)  
  • Centers for Medicare & Medicaid Services (CMS)  
  • National Health Service (NHS)  
  • Ministry of Health and Family Welfare (MoHFW)  
  • National Health Mission (NHM)  
  • Centers for Disease Control and Prevention (CDC)  
  • Food and Drug Administration (FDA)  
  • National Institutes of Health (NIH)  

 

Intravenous (IV) Hydration Therapy Market Report Highlights

Aspects Details
icon_1
Market Size By 2033

USD 4.9 Billion

icon_2
Growth Rate

CAGR of 7.8%

icon_3
Forecast period

2024 - 2033

icon_4
Report Pages

220

icon_5
By Service
  • Immune boosters
  • Energy boosters
  • Skin care
  • Migraine
  • Others
icon_6
By Component
  • Medicated
  • Non-medicated
icon_7
By End User
  • Hospital & clinics
  • Wellness centers & spas
  • Home healthcare
  • Others
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

NexGen Health, B. Braun Medical Inc., Core IV Therapy, LLC, JW Life Science Corporation, Nikkiso Co. Ltd., Davita, Otsuka Pharmaceutical Co., Ltd., Cryojuvenate UK Ltd., Baxter International Inc.?, Amanta Healthcare Limited.

Author Name(s) : NA | Roshan Deshmukh

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Intravenous (IV) Hydration Therapy Market

Global Opportunity Analysis and Industry Forecast, 2024-2033